Federated Hermes’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-227,187
| Closed | -$4.58M | – | 2369 |
|
|
2021
Q3 | $4.58M | Sell |
227,187
-167,114
| -42% | -$3.37M | 0.01% | 844 |
|
|
2021
Q2 | $14.7M | Buy |
394,301
+182,823
| +86% | +$6.82M | 0.03% | 555 |
|
|
2021
Q1 | $5.41M | Buy |
211,478
+211,208
| +78,225% | +$5.4M | 0.01% | 831 |
|
|
2020
Q4 | $6K | Sell |
270
-107,990
| -100% | -$2.4M | ﹤0.01% | 2039 |
|
|
2020
Q3 | $1.95M | Sell |
108,260
-10,136
| -9% | -$182K | ﹤0.01% | 998 |
|
|
2020
Q2 | $3.01M | Sell |
118,396
-38,209
| -24% | -$970K | 0.01% | 851 |
|
|
2020
Q1 | $2.88M | Sell |
156,605
-206,111
| -57% | -$3.79M | 0.01% | 785 |
|
|
2019
Q4 | $7.99M | Buy |
362,716
+228,929
| +171% | +$5.04M | 0.02% | 647 |
|
|
2019
Q3 | $1.92M | Buy |
+133,787
| New | +$1.92M | ﹤0.01% | 1045 |
|
|
2019
Q2 | – | Sell |
-287,961
| Closed | -$4.22M | – | 2255 |
|
|
2019
Q1 | $4.22M | Sell |
287,961
-43,592
| -13% | -$639K | 0.01% | 827 |
|
|
2018
Q4 | $3.54M | Buy |
331,553
+79,058
| +31% | +$845K | 0.01% | 839 |
|
|
2018
Q3 | $3.85M | Buy |
252,495
+252,085
| +61,484% | +$3.85M | 0.01% | 879 |
|
|
2018
Q2 | $5K | Buy |
+410
| New | +$5K | ﹤0.01% | 2022 |
|
|
2017
Q3 | – | Sell |
-541
| Closed | -$2K | – | 2208 |
|
|
2017
Q2 | $2K | Sell |
541
-1,000
| -65% | -$3.7K | ﹤0.01% | 2053 |
|
|
2017
Q1 | $5K | Hold |
1,541
| – | – | ﹤0.01% | 1941 |
|
|
2016
Q4 | $4K | Buy |
1,541
+1,324
| +610% | +$3.44K | ﹤0.01% | 1967 |
|
|
2016
Q3 | $1K | Buy |
+217
| New | +$1K | ﹤0.01% | 2094 |
|
|
2015
Q3 | – | Sell |
-67
| Closed | -$1K | – | 2079 |
|
|
2015
Q2 | $1K | Sell |
67
-264
| -80% | -$3.94K | ﹤0.01% | 1920 |
|
|
2015
Q1 | $8K | Buy |
+331
| New | +$8K | ﹤0.01% | 1807 |
|